AvasimibeMedChemExpress (MCE)美国Avasimibe (CI-1011; PD-148515) 是一种有效的,具有口服活性的酰基辅酶 A: 胆固醇酰基转移酶 (ACAT) 抑制剂,对 ACAT1 和 ACAT2
Avasimibe sodiumTargetMol美国生化试剂,可用于动物细胞实验Product IntroductionBioactivity英文名: Avasimibe sodium描述: Avasimibe sodium
阿拉丁上海 分子式 C29H43NO4S
AvasimibeTargetMol美国生化试剂,可用于动物细胞实验Product IntroductionBioactivity英文名: Avasimibe描述: Avasimibe (PD-148515) 是一种口服有效的酰基辅
TRPV4 antagonist (hTRPV4 IC50 4nM; rTRPV4 IC50 27nM).存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year关键字: PF05214030 | PF 05214030 | Avasimibe sodium salt | PF-05214030
| BAY-3827 | Glabrol | Avasimibe | Beauvericin | Nevanimibe hydrochloride | 2-Furoic acid | PF-06424439 methanesulfonate
相关产品: YM-750 | RU-SKI 43 | Xanthohumol | A 922500 | OSMI-1 | Lateritin | BAY-3827 | Avasimibe | YM17E | 2-Furoic acid
| PF-04620110 | Avasimibe | RP-64477 | Eldacimibe | T863 | 2-Furoic acid | PF-06424439 methanesulfonate | PF-06424439
| 24-Methylenecholesterol | Lecimibide | Rimonabant | Avasimibe | PF-07202954 | BMS-986172 | T863 | K-604 dihydrochloride
| Naringenin | Metyrapone | Myristicin | Ayanin | Danshensu sodium salt | 2,3-dihydrothieno-Thiadiazole Carboxylate | Avasimibe
祝贺!第十五届光华工程科技奖获奖名单公布,这41名专家获奖
安捷伦在ASMS:智能推动性能 挑战极限应用
2024代谢学组学年会LECO力可公司及用户科技动态
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net